| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Lysophosphatidic Acid | 13 | 2015 | 77 | 1.350 |
Why?
|
| RANK Ligand | 4 | 2020 | 318 | 0.900 |
Why?
|
| DNA-Binding Proteins | 50 | 2023 | 9590 | 0.830 |
Why?
|
| Bone Resorption | 4 | 2020 | 720 | 0.770 |
Why?
|
| Osteocytes | 3 | 2020 | 192 | 0.770 |
Why?
|
| Lysophospholipids | 14 | 2015 | 339 | 0.740 |
Why?
|
| Transcription Factors | 51 | 2023 | 12100 | 0.710 |
Why?
|
| Cell Nucleolus | 1 | 2018 | 156 | 0.600 |
Why?
|
| Osteoclasts | 3 | 2018 | 712 | 0.560 |
Why?
|
| Erythroid Cells | 6 | 2022 | 235 | 0.500 |
Why?
|
| Gene Expression Regulation, Developmental | 21 | 2020 | 3601 | 0.490 |
Why?
|
| GATA1 Transcription Factor | 15 | 2020 | 296 | 0.480 |
Why?
|
| Hematopoietic Stem Cells | 15 | 2020 | 3390 | 0.470 |
Why?
|
| Embryonic Stem Cells | 10 | 2015 | 1262 | 0.470 |
Why?
|
| Hematopoiesis | 18 | 2020 | 2063 | 0.460 |
Why?
|
| Nuclear Proteins | 16 | 2022 | 5793 | 0.450 |
Why?
|
| Phosphatidic Acids | 3 | 2010 | 49 | 0.410 |
Why?
|
| Tumor Suppressor Protein p53 | 3 | 2018 | 2927 | 0.410 |
Why?
|
| Mice | 110 | 2024 | 81216 | 0.410 |
Why?
|
| Enhancer Elements, Genetic | 7 | 2020 | 1356 | 0.380 |
Why?
|
| Fetal Hemoglobin | 5 | 2019 | 342 | 0.370 |
Why?
|
| Bone Marrow Cells | 5 | 2017 | 2424 | 0.360 |
Why?
|
| Estrogens | 2 | 2018 | 1520 | 0.360 |
Why?
|
| Erythropoiesis | 12 | 2020 | 682 | 0.350 |
Why?
|
| Carrier Proteins | 12 | 2022 | 4938 | 0.340 |
Why?
|
| Animals | 124 | 2024 | 167940 | 0.330 |
Why?
|
| Megakaryocytes | 12 | 2017 | 566 | 0.330 |
Why?
|
| Laboratory Animal Science | 1 | 2008 | 9 | 0.310 |
Why?
|
| Cell Differentiation | 27 | 2015 | 11480 | 0.300 |
Why?
|
| Mice, Knockout | 42 | 2020 | 14396 | 0.300 |
Why?
|
| Mice, Transgenic | 29 | 2019 | 9531 | 0.300 |
Why?
|
| Receptors, Lysosphingolipid | 4 | 2011 | 121 | 0.290 |
Why?
|
| Cell Lineage | 11 | 2020 | 2525 | 0.280 |
Why?
|
| MicroRNAs | 4 | 2018 | 3784 | 0.270 |
Why?
|
| B-Lymphocytes | 4 | 2016 | 4739 | 0.270 |
Why?
|
| Zinc Fingers | 8 | 2002 | 568 | 0.260 |
Why?
|
| Embryo, Mammalian | 15 | 2015 | 1667 | 0.250 |
Why?
|
| Platelet Activation | 1 | 2009 | 661 | 0.250 |
Why?
|
| Repressor Proteins | 13 | 2022 | 2978 | 0.250 |
Why?
|
| Mutagenesis | 4 | 2019 | 1234 | 0.240 |
Why?
|
| Proto-Oncogene Proteins | 12 | 2015 | 4494 | 0.240 |
Why?
|
| Pyridoxine | 1 | 2024 | 108 | 0.230 |
Why?
|
| 5-Aminolevulinate Synthetase | 1 | 2024 | 64 | 0.230 |
Why?
|
| GATA2 Transcription Factor | 6 | 2023 | 158 | 0.230 |
Why?
|
| Embryo Transfer | 1 | 2008 | 521 | 0.230 |
Why?
|
| Anemia, Sideroblastic | 1 | 2024 | 109 | 0.220 |
Why?
|
| GATA4 Transcription Factor | 4 | 2008 | 124 | 0.220 |
Why?
|
| Analgesia | 1 | 2008 | 459 | 0.220 |
Why?
|
| Adenocarcinoma | 2 | 2018 | 6310 | 0.210 |
Why?
|
| Glycerol | 1 | 2003 | 277 | 0.210 |
Why?
|
| Cell Movement | 7 | 2020 | 5206 | 0.200 |
Why?
|
| Proto-Oncogene Proteins c-ets | 4 | 2020 | 311 | 0.200 |
Why?
|
| Chromatin | 7 | 2022 | 2939 | 0.200 |
Why?
|
| Erythroid-Specific DNA-Binding Factors | 12 | 2003 | 195 | 0.200 |
Why?
|
| Gene Expression Regulation | 16 | 2019 | 11902 | 0.190 |
Why?
|
| Genes, Reporter | 5 | 2020 | 1531 | 0.190 |
Why?
|
| Apoptosis | 12 | 2020 | 9497 | 0.190 |
Why?
|
| Retinoblastoma Protein | 2 | 2017 | 671 | 0.180 |
Why?
|
| Nerve Growth Factors | 1 | 2003 | 562 | 0.180 |
Why?
|
| Cadherins | 2 | 2015 | 898 | 0.180 |
Why?
|
| Gastric Mucosa | 1 | 2023 | 599 | 0.180 |
Why?
|
| Leukemia, Myeloid | 1 | 2023 | 696 | 0.180 |
Why?
|
| Buprenorphine | 1 | 2008 | 653 | 0.170 |
Why?
|
| Erythrocytes | 9 | 2006 | 2415 | 0.170 |
Why?
|
| Fibroblasts | 9 | 2017 | 4091 | 0.170 |
Why?
|
| Sphingosine | 4 | 2011 | 308 | 0.170 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 9 | 2015 | 1137 | 0.170 |
Why?
|
| Mesoderm | 3 | 2015 | 671 | 0.170 |
Why?
|
| Mutagenesis, Site-Directed | 7 | 2009 | 1694 | 0.170 |
Why?
|
| HCT116 Cells | 2 | 2018 | 402 | 0.170 |
Why?
|
| Molecular Sequence Data | 21 | 2015 | 17628 | 0.170 |
Why?
|
| Stomach | 1 | 2023 | 695 | 0.160 |
Why?
|
| Mice, Inbred C57BL | 25 | 2020 | 22025 | 0.160 |
Why?
|
| Facial Paralysis | 1 | 2023 | 345 | 0.160 |
Why?
|
| Antigens, Ly | 1 | 2020 | 293 | 0.160 |
Why?
|
| Intestine, Small | 4 | 2010 | 1207 | 0.160 |
Why?
|
| Cell Line | 20 | 2020 | 15626 | 0.160 |
Why?
|
| Biliary Tract Neoplasms | 1 | 2020 | 184 | 0.160 |
Why?
|
| Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2019 | 114 | 0.160 |
Why?
|
| Cell Cycle Proteins | 6 | 2012 | 3448 | 0.160 |
Why?
|
| Integrases | 5 | 2017 | 516 | 0.160 |
Why?
|
| Yolk Sac | 5 | 2003 | 79 | 0.150 |
Why?
|
| Cell Line, Tumor | 13 | 2018 | 16905 | 0.150 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2020 | 352 | 0.150 |
Why?
|
| Testis | 4 | 2013 | 794 | 0.150 |
Why?
|
| Pluripotent Stem Cells | 2 | 2015 | 791 | 0.150 |
Why?
|
| Pain, Postoperative | 1 | 2008 | 1718 | 0.150 |
Why?
|
| Green Fluorescent Proteins | 6 | 2020 | 2056 | 0.140 |
Why?
|
| Gene Targeting | 13 | 2015 | 839 | 0.140 |
Why?
|
| Gene Silencing | 5 | 2016 | 1511 | 0.140 |
Why?
|
| Cells, Cultured | 15 | 2020 | 18968 | 0.140 |
Why?
|
| Protein-Arginine N-Methyltransferases | 1 | 2017 | 131 | 0.140 |
Why?
|
| Anemia, Hemolytic | 2 | 2016 | 163 | 0.140 |
Why?
|
| Receptors, G-Protein-Coupled | 3 | 2011 | 1244 | 0.130 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 2 | 2010 | 474 | 0.130 |
Why?
|
| Cell Transdifferentiation | 1 | 2017 | 185 | 0.130 |
Why?
|
| Proto-Oncogene Proteins c-myc | 4 | 2013 | 995 | 0.130 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 2 | 2010 | 478 | 0.130 |
Why?
|
| Osteoprotegerin | 1 | 2016 | 177 | 0.130 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2020 | 730 | 0.130 |
Why?
|
| Signal Transduction | 11 | 2017 | 23363 | 0.130 |
Why?
|
| Hemangioblasts | 1 | 2015 | 28 | 0.130 |
Why?
|
| Base Sequence | 16 | 2016 | 12447 | 0.130 |
Why?
|
| Oncogene Proteins | 2 | 2017 | 721 | 0.130 |
Why?
|
| Naphthalimides | 1 | 2015 | 22 | 0.130 |
Why?
|
| Iron-Binding Proteins | 2 | 2005 | 79 | 0.120 |
Why?
|
| Myoblasts, Cardiac | 1 | 2015 | 21 | 0.120 |
Why?
|
| Ligands | 5 | 2011 | 3277 | 0.120 |
Why?
|
| Adipocytes | 3 | 2017 | 1179 | 0.120 |
Why?
|
| Acids | 1 | 2015 | 125 | 0.120 |
Why?
|
| Erythrocyte Membrane | 1 | 2016 | 439 | 0.120 |
Why?
|
| Globins | 3 | 2009 | 403 | 0.120 |
Why?
|
| Neoplasm Transplantation | 1 | 2018 | 2014 | 0.120 |
Why?
|
| Iron | 5 | 2005 | 1786 | 0.120 |
Why?
|
| Propylene Glycols | 2 | 2011 | 90 | 0.120 |
Why?
|
| Lung Neoplasms | 2 | 2018 | 13249 | 0.120 |
Why?
|
| Cytoskeleton | 3 | 2016 | 1167 | 0.120 |
Why?
|
| Flow Cytometry | 8 | 2020 | 5873 | 0.120 |
Why?
|
| Protein Biosynthesis | 2 | 2017 | 2104 | 0.110 |
Why?
|
| Gene Expression Profiling | 7 | 2020 | 9388 | 0.110 |
Why?
|
| Bone Neoplasms | 2 | 2017 | 2532 | 0.110 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2018 | 3774 | 0.110 |
Why?
|
| Viral Matrix Proteins | 1 | 2015 | 197 | 0.110 |
Why?
|
| Trophoblasts | 1 | 2015 | 224 | 0.110 |
Why?
|
| gamma-Globins | 2 | 2011 | 96 | 0.110 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2020 | 4554 | 0.110 |
Why?
|
| Amino Acid Sequence | 13 | 2009 | 13456 | 0.110 |
Why?
|
| Cell Transformation, Viral | 1 | 2015 | 526 | 0.110 |
Why?
|
| Gene Dosage | 2 | 2017 | 1218 | 0.110 |
Why?
|
| Multipotent Stem Cells | 2 | 2006 | 200 | 0.110 |
Why?
|
| Structure-Activity Relationship | 3 | 2009 | 3086 | 0.110 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2020 | 8498 | 0.110 |
Why?
|
| Phosphodiesterase I | 2 | 2010 | 7 | 0.110 |
Why?
|
| Histone Demethylases | 2 | 2013 | 323 | 0.110 |
Why?
|
| Pulmonary Surfactant-Associated Protein C | 1 | 2012 | 30 | 0.110 |
Why?
|
| Membrane Proteins | 6 | 2020 | 7854 | 0.110 |
Why?
|
| Gene Deletion | 5 | 2016 | 2668 | 0.110 |
Why?
|
| Hemoglobinopathies | 1 | 2013 | 96 | 0.110 |
Why?
|
| Protein Structure, Tertiary | 6 | 2015 | 3800 | 0.110 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 1 | 2013 | 174 | 0.100 |
Why?
|
| Cation Transport Proteins | 2 | 2005 | 325 | 0.100 |
Why?
|
| Cell Proliferation | 6 | 2020 | 10434 | 0.100 |
Why?
|
| Gene Regulatory Networks | 2 | 2012 | 1740 | 0.100 |
Why?
|
| Genetic Engineering | 2 | 2015 | 933 | 0.100 |
Why?
|
| Pyrophosphatases | 2 | 2010 | 139 | 0.100 |
Why?
|
| Proteome | 1 | 2022 | 1856 | 0.100 |
Why?
|
| Bone Marrow | 3 | 2013 | 2918 | 0.100 |
Why?
|
| Receptors, Chemokine | 2 | 2005 | 654 | 0.100 |
Why?
|
| Placenta | 2 | 2015 | 1701 | 0.100 |
Why?
|
| Cytoskeletal Proteins | 2 | 2016 | 1344 | 0.100 |
Why?
|
| Retinol-Binding Proteins, Cellular | 1 | 2011 | 12 | 0.100 |
Why?
|
| Histones | 6 | 2015 | 2583 | 0.100 |
Why?
|
| Epithelial Cells | 5 | 2023 | 3665 | 0.100 |
Why?
|
| Stem Cells | 8 | 2023 | 3525 | 0.100 |
Why?
|
| Analgesics, Opioid | 1 | 2008 | 3762 | 0.100 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2016 | 685 | 0.100 |
Why?
|
| Adult Stem Cells | 1 | 2013 | 221 | 0.100 |
Why?
|
| Osteosarcoma | 1 | 2017 | 898 | 0.100 |
Why?
|
| Embryonic and Fetal Development | 7 | 2000 | 420 | 0.090 |
Why?
|
| Small Molecule Libraries | 1 | 2017 | 734 | 0.090 |
Why?
|
| 5' Flanking Region | 1 | 2010 | 31 | 0.090 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 2014 | 545 | 0.090 |
Why?
|
| Cullin Proteins | 1 | 2012 | 178 | 0.090 |
Why?
|
| VDJ Recombinases | 1 | 2011 | 84 | 0.090 |
Why?
|
| Hippocampus | 1 | 2003 | 3737 | 0.090 |
Why?
|
| Homeodomain Proteins | 6 | 2013 | 2414 | 0.090 |
Why?
|
| Multienzyme Complexes | 3 | 2010 | 666 | 0.090 |
Why?
|
| Sequence Homology, Amino Acid | 4 | 2009 | 2755 | 0.090 |
Why?
|
| Chromatin Immunoprecipitation | 4 | 2015 | 859 | 0.090 |
Why?
|
| DNA-Activated Protein Kinase | 1 | 2011 | 112 | 0.090 |
Why?
|
| F-Box Proteins | 1 | 2012 | 202 | 0.090 |
Why?
|
| Phospholipase D | 1 | 2010 | 67 | 0.090 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2011 | 358 | 0.090 |
Why?
|
| PPAR gamma | 2 | 2010 | 484 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 7 | 2015 | 4573 | 0.090 |
Why?
|
| Zebrafish Proteins | 3 | 2008 | 1006 | 0.090 |
Why?
|
| Immunity, Humoral | 1 | 2014 | 604 | 0.090 |
Why?
|
| Disease Models, Animal | 5 | 2024 | 18134 | 0.080 |
Why?
|
| Osteoblasts | 1 | 2015 | 1142 | 0.080 |
Why?
|
| Rats | 9 | 2012 | 23695 | 0.080 |
Why?
|
| Antibody Formation | 1 | 2014 | 1400 | 0.080 |
Why?
|
| Receptors, CCR10 | 1 | 2008 | 9 | 0.080 |
Why?
|
| Liver | 6 | 2013 | 7512 | 0.080 |
Why?
|
| Germ Cells | 1 | 2013 | 635 | 0.080 |
Why?
|
| High Mobility Group Proteins | 2 | 2007 | 176 | 0.080 |
Why?
|
| Viral Proteins | 3 | 2001 | 1802 | 0.080 |
Why?
|
| Recombination, Genetic | 3 | 2011 | 1526 | 0.080 |
Why?
|
| Stereoisomerism | 2 | 2010 | 618 | 0.080 |
Why?
|
| Models, Molecular | 3 | 2009 | 5429 | 0.080 |
Why?
|
| Antigens, CD | 3 | 2015 | 4002 | 0.080 |
Why?
|
| Binding Sites | 5 | 2015 | 6050 | 0.080 |
Why?
|
| Antibody-Producing Cells | 1 | 2008 | 140 | 0.080 |
Why?
|
| Genes, Tumor Suppressor | 2 | 2011 | 1056 | 0.080 |
Why?
|
| Callithrix | 1 | 2008 | 93 | 0.080 |
Why?
|
| Neoplastic Stem Cells | 1 | 2016 | 1347 | 0.080 |
Why?
|
| Lymphoma, B-Cell | 1 | 2015 | 935 | 0.080 |
Why?
|
| Fertility | 1 | 2013 | 772 | 0.080 |
Why?
|
| Recombinant Proteins | 4 | 2020 | 6543 | 0.080 |
Why?
|
| Myelopoiesis | 2 | 2006 | 134 | 0.080 |
Why?
|
| Erythroblasts | 2 | 2020 | 143 | 0.070 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2008 | 220 | 0.070 |
Why?
|
| Calcium Signaling | 2 | 2009 | 731 | 0.070 |
Why?
|
| Nerve Tissue Proteins | 3 | 2009 | 4409 | 0.070 |
Why?
|
| Genes, Regulator | 1 | 2008 | 374 | 0.070 |
Why?
|
| Transcription, Genetic | 5 | 2013 | 7593 | 0.070 |
Why?
|
| Adaptor Proteins, Signal Transducing | 5 | 2012 | 2895 | 0.070 |
Why?
|
| Promoter Regions, Genetic | 6 | 2020 | 5784 | 0.070 |
Why?
|
| Alcohol Oxidoreductases | 1 | 2008 | 169 | 0.070 |
Why?
|
| Ubiquitination | 1 | 2012 | 1010 | 0.070 |
Why?
|
| Cloning, Molecular | 8 | 2008 | 4172 | 0.070 |
Why?
|
| Mutation, Missense | 2 | 2007 | 2563 | 0.070 |
Why?
|
| DNA, Complementary | 6 | 2005 | 1993 | 0.070 |
Why?
|
| Cell Survival | 4 | 2004 | 5796 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-raf | 1 | 2007 | 203 | 0.070 |
Why?
|
| Glucocorticoids | 1 | 2016 | 2143 | 0.070 |
Why?
|
| Transfection | 6 | 2005 | 5782 | 0.070 |
Why?
|
| Neurons | 2 | 2003 | 9416 | 0.070 |
Why?
|
| Kruppel-Like Transcription Factors | 2 | 2008 | 503 | 0.070 |
Why?
|
| Transferrin | 2 | 2005 | 284 | 0.070 |
Why?
|
| Amino Acid Substitution | 2 | 2009 | 1737 | 0.070 |
Why?
|
| Noonan Syndrome | 1 | 2007 | 120 | 0.070 |
Why?
|
| Lymphocyte Activation | 3 | 2013 | 5498 | 0.070 |
Why?
|
| RNA, Messenger | 11 | 2015 | 12762 | 0.070 |
Why?
|
| Age Factors | 3 | 2020 | 18415 | 0.070 |
Why?
|
| Female | 33 | 2020 | 391011 | 0.070 |
Why?
|
| FMN Reductase | 1 | 2005 | 13 | 0.070 |
Why?
|
| Disorders of Sex Development | 1 | 2007 | 129 | 0.070 |
Why?
|
| Induced Pluripotent Stem Cells | 2 | 2015 | 1843 | 0.070 |
Why?
|
| Tumor Cells, Cultured | 3 | 2020 | 6131 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2010 | 10829 | 0.070 |
Why?
|
| Embryo Implantation | 1 | 2008 | 270 | 0.070 |
Why?
|
| Integrins | 1 | 2010 | 840 | 0.070 |
Why?
|
| Phosphoric Diester Hydrolases | 3 | 2013 | 199 | 0.070 |
Why?
|
| Humans | 48 | 2024 | 760261 | 0.060 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2008 | 663 | 0.060 |
Why?
|
| Complement C5a | 1 | 2005 | 100 | 0.060 |
Why?
|
| Baculoviridae | 1 | 2005 | 115 | 0.060 |
Why?
|
| Xenograft Model Antitumor Assays | 3 | 2020 | 3584 | 0.060 |
Why?
|
| Androgens | 1 | 2013 | 1289 | 0.060 |
Why?
|
| Radiation Injuries | 1 | 2013 | 1183 | 0.060 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2010 | 1078 | 0.060 |
Why?
|
| Male | 27 | 2024 | 359413 | 0.060 |
Why?
|
| Immunoglobulin A | 1 | 2008 | 978 | 0.060 |
Why?
|
| In Situ Hybridization | 7 | 2007 | 1900 | 0.060 |
Why?
|
| Sulfonamides | 1 | 2015 | 1973 | 0.060 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2005 | 184 | 0.060 |
Why?
|
| Leishmania major | 1 | 2005 | 59 | 0.060 |
Why?
|
| Cleft Palate | 1 | 2010 | 587 | 0.060 |
Why?
|
| Protein Binding | 8 | 2012 | 9336 | 0.060 |
Why?
|
| Spinal Cord | 2 | 2005 | 1817 | 0.060 |
Why?
|
| Acute Radiation Syndrome | 2 | 2015 | 2 | 0.060 |
Why?
|
| Fetal Heart | 2 | 2003 | 281 | 0.060 |
Why?
|
| Central Nervous System | 2 | 2004 | 1334 | 0.060 |
Why?
|
| Mice, Inbred BALB C | 4 | 2020 | 6226 | 0.060 |
Why?
|
| RNA-Binding Proteins | 1 | 2013 | 1892 | 0.060 |
Why?
|
| T-Lymphocytes | 4 | 2010 | 10183 | 0.060 |
Why?
|
| Lysine | 1 | 2008 | 1002 | 0.060 |
Why?
|
| Protoporphyria, Erythropoietic | 1 | 2024 | 55 | 0.060 |
Why?
|
| Immunologic Surveillance | 2 | 2015 | 92 | 0.060 |
Why?
|
| Culture Media, Serum-Free | 1 | 2003 | 148 | 0.060 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 2 | 1999 | 789 | 0.060 |
Why?
|
| Anemia, Megaloblastic | 1 | 2003 | 24 | 0.060 |
Why?
|
| Endothelial Cells | 2 | 2008 | 3537 | 0.060 |
Why?
|
| Diphosphates | 1 | 2003 | 84 | 0.060 |
Why?
|
| Motor Neurons | 3 | 2023 | 865 | 0.060 |
Why?
|
| Pyloric Antrum | 1 | 2023 | 66 | 0.060 |
Why?
|
| Valine | 1 | 2005 | 409 | 0.060 |
Why?
|
| Transcriptional Activation | 4 | 2011 | 1755 | 0.060 |
Why?
|
| Guanosine | 1 | 2003 | 49 | 0.060 |
Why?
|
| Blotting, Western | 5 | 2015 | 5039 | 0.060 |
Why?
|
| DNA Fragmentation | 2 | 2015 | 237 | 0.060 |
Why?
|
| Immunoglobulin Switch Region | 1 | 2003 | 45 | 0.060 |
Why?
|
| Lung | 4 | 2012 | 9989 | 0.050 |
Why?
|
| S Phase | 2 | 2001 | 422 | 0.050 |
Why?
|
| Prognosis | 3 | 2020 | 29636 | 0.050 |
Why?
|
| Models, Chemical | 1 | 2005 | 614 | 0.050 |
Why?
|
| Peroxidases | 1 | 2003 | 135 | 0.050 |
Why?
|
| Leishmaniasis, Cutaneous | 1 | 2005 | 136 | 0.050 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2005 | 617 | 0.050 |
Why?
|
| Aging | 3 | 2020 | 8641 | 0.050 |
Why?
|
| Neurons, Efferent | 1 | 2023 | 81 | 0.050 |
Why?
|
| Anemia, Sickle Cell | 1 | 2011 | 1056 | 0.050 |
Why?
|
| Cholera Toxin | 1 | 2005 | 559 | 0.050 |
Why?
|
| Mutation | 13 | 2023 | 29950 | 0.050 |
Why?
|
| Platelet Membrane Glycoprotein IIb | 1 | 2002 | 52 | 0.050 |
Why?
|
| Recombinant Fusion Proteins | 7 | 2011 | 3735 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2007 | 1246 | 0.050 |
Why?
|
| rac GTP-Binding Proteins | 1 | 2003 | 162 | 0.050 |
Why?
|
| Alanine | 1 | 2005 | 607 | 0.050 |
Why?
|
| Heart | 3 | 2007 | 4392 | 0.050 |
Why?
|
| Gamma Rays | 2 | 2015 | 317 | 0.050 |
Why?
|
| Sequence Deletion | 3 | 2002 | 1493 | 0.050 |
Why?
|
| Organic Anion Transporters, Sodium-Independent | 1 | 2002 | 28 | 0.050 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2005 | 446 | 0.050 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2006 | 685 | 0.050 |
Why?
|
| Sex Determination Processes | 1 | 2002 | 59 | 0.050 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2012 | 1890 | 0.050 |
Why?
|
| Crosses, Genetic | 1 | 2003 | 751 | 0.050 |
Why?
|
| Computational Biology | 2 | 2012 | 3504 | 0.050 |
Why?
|
| Eosinophils | 3 | 2002 | 946 | 0.050 |
Why?
|
| Anions | 1 | 2002 | 137 | 0.050 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2003 | 277 | 0.050 |
Why?
|
| Phosphorylation | 4 | 2010 | 8314 | 0.050 |
Why?
|
| Multigene Family | 1 | 2005 | 1079 | 0.050 |
Why?
|
| Mice, Mutant Strains | 5 | 2005 | 1760 | 0.050 |
Why?
|
| Body Patterning | 2 | 2004 | 630 | 0.050 |
Why?
|
| Chimera | 5 | 2003 | 453 | 0.050 |
Why?
|
| Amino Acids | 1 | 2008 | 1715 | 0.050 |
Why?
|
| Mice, Nude | 2 | 2020 | 3605 | 0.050 |
Why?
|
| Arginine | 1 | 2005 | 934 | 0.050 |
Why?
|
| DNA Primers | 4 | 2011 | 2819 | 0.050 |
Why?
|
| Neurites | 1 | 2003 | 389 | 0.050 |
Why?
|
| Glycosylphosphatidylinositols | 1 | 2001 | 90 | 0.050 |
Why?
|
| Organ Specificity | 3 | 2015 | 1955 | 0.050 |
Why?
|
| Receptors, Notch | 1 | 2006 | 742 | 0.050 |
Why?
|
| Estrone | 1 | 2002 | 232 | 0.050 |
Why?
|
| Anemia, Iron-Deficiency | 1 | 2005 | 368 | 0.050 |
Why?
|
| Self Tolerance | 1 | 2001 | 124 | 0.050 |
Why?
|
| eIF-2 Kinase | 1 | 2001 | 144 | 0.050 |
Why?
|
| Metalloproteins | 2 | 1999 | 101 | 0.050 |
Why?
|
| Luminescent Proteins | 2 | 2001 | 835 | 0.050 |
Why?
|
| Enzyme Inhibitors | 3 | 2011 | 3726 | 0.050 |
Why?
|
| Hypertension, Pulmonary | 1 | 2012 | 1570 | 0.050 |
Why?
|
| Response Elements | 1 | 2002 | 308 | 0.050 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2005 | 2509 | 0.050 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2024 | 378 | 0.050 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2011 | 2804 | 0.040 |
Why?
|
| Cytoprotection | 2 | 2013 | 200 | 0.040 |
Why?
|
| Neovascularization, Physiologic | 2 | 1998 | 1335 | 0.040 |
Why?
|
| Animals, Newborn | 3 | 2013 | 2671 | 0.040 |
Why?
|
| Deoxyribonuclease I | 2 | 1999 | 224 | 0.040 |
Why?
|
| Enzyme Activation | 3 | 2013 | 3604 | 0.040 |
Why?
|
| Infertility, Male | 1 | 2003 | 396 | 0.040 |
Why?
|
| Nervous System | 2 | 2004 | 543 | 0.040 |
Why?
|
| Erythroid Precursor Cells | 2 | 1998 | 211 | 0.040 |
Why?
|
| Receptor, erbB-2 | 1 | 2010 | 2544 | 0.040 |
Why?
|
| Proteins | 4 | 2004 | 6030 | 0.040 |
Why?
|
| Receptors, Complement | 1 | 2000 | 253 | 0.040 |
Why?
|
| Th1 Cells | 1 | 2005 | 1033 | 0.040 |
Why?
|
| Cell Division | 6 | 2004 | 4462 | 0.040 |
Why?
|
| Intestinal Absorption | 3 | 2008 | 401 | 0.040 |
Why?
|
| Immunophenotyping | 3 | 2015 | 1870 | 0.040 |
Why?
|
| Neoplasms | 5 | 2011 | 22066 | 0.040 |
Why?
|
| Colonic Neoplasms | 1 | 2011 | 2526 | 0.040 |
Why?
|
| Cell Adhesion | 3 | 2015 | 3096 | 0.040 |
Why?
|
| 3T3-L1 Cells | 2 | 2010 | 209 | 0.040 |
Why?
|
| Phenotype | 7 | 2017 | 16543 | 0.040 |
Why?
|
| Embryo, Nonmammalian | 2 | 2015 | 899 | 0.040 |
Why?
|
| Blotting, Northern | 4 | 2002 | 1544 | 0.040 |
Why?
|
| Diarrhea | 1 | 2005 | 1341 | 0.040 |
Why?
|
| Species Specificity | 2 | 2015 | 2413 | 0.040 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 2 | 2023 | 1614 | 0.040 |
Why?
|
| Antigens, Nuclear | 1 | 1998 | 184 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 1 | 2015 | 9196 | 0.040 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 1998 | 149 | 0.040 |
Why?
|
| Spermatogenesis | 2 | 2013 | 257 | 0.040 |
Why?
|
| Ovary | 1 | 2002 | 959 | 0.040 |
Why?
|
| Microfilament Proteins | 1 | 2003 | 1134 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2012 | 8157 | 0.040 |
Why?
|
| Astrocytes | 1 | 2005 | 1335 | 0.040 |
Why?
|
| Myocytes, Cardiac | 1 | 2006 | 1656 | 0.040 |
Why?
|
| HEK293 Cells | 3 | 2012 | 4264 | 0.040 |
Why?
|
| Membrane Transport Proteins | 1 | 2003 | 1036 | 0.040 |
Why?
|
| Lymphocyte Subsets | 1 | 1998 | 310 | 0.040 |
Why?
|
| Kinetics | 1 | 2005 | 6378 | 0.040 |
Why?
|
| Amino Acid Motifs | 2 | 2011 | 929 | 0.040 |
Why?
|
| Antigens, Neoplasm | 1 | 2005 | 1999 | 0.040 |
Why?
|
| Protein Conformation | 1 | 2005 | 3969 | 0.040 |
Why?
|
| Receptors, Transferrin | 1 | 1999 | 291 | 0.040 |
Why?
|
| Single-Cell Analysis | 2 | 2020 | 2368 | 0.040 |
Why?
|
| Methylation | 2 | 2011 | 1080 | 0.040 |
Why?
|
| E2F1 Transcription Factor | 3 | 2001 | 178 | 0.040 |
Why?
|
| Transduction, Genetic | 1 | 2020 | 897 | 0.040 |
Why?
|
| Zebrafish | 4 | 2015 | 2996 | 0.040 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2019 | 453 | 0.040 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2001 | 1173 | 0.040 |
Why?
|
| E2F Transcription Factors | 3 | 2001 | 269 | 0.040 |
Why?
|
| Mammary Glands, Human | 1 | 2018 | 204 | 0.030 |
Why?
|
| Conserved Sequence | 3 | 2008 | 1168 | 0.030 |
Why?
|
| Gene Library | 2 | 2015 | 1060 | 0.030 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1998 | 489 | 0.030 |
Why?
|
| Neurogenesis | 1 | 2023 | 855 | 0.030 |
Why?
|
| Antimetabolites | 1 | 2017 | 127 | 0.030 |
Why?
|
| Macrophages | 2 | 2010 | 5745 | 0.030 |
Why?
|
| Trans-Activators | 2 | 2013 | 2861 | 0.030 |
Why?
|
| Leukemia | 3 | 1999 | 1522 | 0.030 |
Why?
|
| Genetic Complementation Test | 1 | 2017 | 555 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2017 | 285 | 0.030 |
Why?
|
| Genomics | 3 | 2020 | 5790 | 0.030 |
Why?
|
| Antigens | 1 | 2001 | 1447 | 0.030 |
Why?
|
| Ovariectomy | 1 | 2018 | 611 | 0.030 |
Why?
|
| Muscle Cells | 1 | 2017 | 195 | 0.030 |
Why?
|
| Mesonephros | 1 | 2015 | 41 | 0.030 |
Why?
|
| Cell Compartmentation | 1 | 2016 | 385 | 0.030 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2005 | 1799 | 0.030 |
Why?
|
| Gene Expression | 3 | 2020 | 7592 | 0.030 |
Why?
|
| Spectrin | 1 | 2016 | 170 | 0.030 |
Why?
|
| Actins | 1 | 2003 | 2049 | 0.030 |
Why?
|
| Models, Biological | 5 | 2015 | 9468 | 0.030 |
Why?
|
| Porosity | 1 | 2016 | 349 | 0.030 |
Why?
|
| Alleles | 3 | 2012 | 6900 | 0.030 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2006 | 1634 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 1998 | 642 | 0.030 |
Why?
|
| Prednisolone | 1 | 2016 | 328 | 0.030 |
Why?
|
| Antioxidants | 1 | 2003 | 1668 | 0.030 |
Why?
|
| Gonads | 2 | 2007 | 109 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2003 | 2449 | 0.030 |
Why?
|
| Calmodulin-Binding Proteins | 1 | 2016 | 232 | 0.030 |
Why?
|
| Histone-Lysine N-Methyltransferase | 2 | 2009 | 679 | 0.030 |
Why?
|
| Hair | 1 | 1998 | 492 | 0.030 |
Why?
|
| Melanoma | 1 | 2013 | 5695 | 0.030 |
Why?
|
| Lung Injury | 2 | 2012 | 424 | 0.030 |
Why?
|
| Models, Genetic | 4 | 2008 | 3442 | 0.030 |
Why?
|
| HeLa Cells | 2 | 2012 | 3105 | 0.030 |
Why?
|
| Intestines | 1 | 2023 | 1907 | 0.030 |
Why?
|
| Caspase 8 | 1 | 2015 | 188 | 0.030 |
Why?
|
| GTP-Binding Protein alpha Subunits, G12-G13 | 1 | 2014 | 43 | 0.030 |
Why?
|
| Fusion Proteins, bcr-abl | 1 | 2016 | 431 | 0.030 |
Why?
|
| SOX9 Transcription Factor | 2 | 2007 | 145 | 0.030 |
Why?
|
| Microscopy, Confocal | 2 | 2015 | 1972 | 0.030 |
Why?
|
| Electroporation | 1 | 2015 | 256 | 0.030 |
Why?
|
| Neoplastic Processes | 1 | 2013 | 35 | 0.030 |
Why?
|
| Blood Vessels | 1 | 1999 | 1112 | 0.030 |
Why?
|
| Kidney | 3 | 2005 | 7072 | 0.030 |
Why?
|
| Cell Adhesion Molecules | 1 | 2000 | 1602 | 0.030 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 2008 | 1056 | 0.030 |
Why?
|
| Autoimmunity | 1 | 2001 | 1370 | 0.030 |
Why?
|
| Luciferases | 1 | 2015 | 716 | 0.030 |
Why?
|
| DNA Helicases | 1 | 1998 | 854 | 0.030 |
Why?
|
| Oncogenes | 1 | 1999 | 1221 | 0.030 |
Why?
|
| Receptor, Anaphylatoxin C5a | 2 | 2005 | 87 | 0.030 |
Why?
|
| Genotype | 4 | 2015 | 12959 | 0.030 |
Why?
|
| Bronchioles | 1 | 2012 | 30 | 0.030 |
Why?
|
| Precursor Cells, B-Lymphoid | 1 | 2013 | 98 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 58947 | 0.030 |
Why?
|
| Genetic Vectors | 2 | 2001 | 3378 | 0.030 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2016 | 645 | 0.030 |
Why?
|
| GTP-Binding Proteins | 2 | 2009 | 951 | 0.030 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2009 | 2874 | 0.030 |
Why?
|
| Bromodeoxyuridine | 2 | 2004 | 310 | 0.030 |
Why?
|
| Fetus | 2 | 2010 | 1859 | 0.030 |
Why?
|
| Bystander Effect | 1 | 2013 | 90 | 0.030 |
Why?
|
| Mast Cells | 4 | 2002 | 1428 | 0.030 |
Why?
|
| E2F2 Transcription Factor | 2 | 2001 | 35 | 0.030 |
Why?
|
| Cell Count | 1 | 2016 | 1838 | 0.030 |
Why?
|
| Homozygote | 3 | 2005 | 1786 | 0.030 |
Why?
|
| Calcium | 1 | 2005 | 5726 | 0.030 |
Why?
|
| Immunoenzyme Techniques | 1 | 2015 | 1705 | 0.030 |
Why?
|
| Antigens, Differentiation, B-Lymphocyte | 1 | 2012 | 317 | 0.030 |
Why?
|
| Molecular Structure | 2 | 2007 | 1895 | 0.030 |
Why?
|
| Paraganglioma, Extra-Adrenal | 1 | 2012 | 45 | 0.030 |
Why?
|
| Transgenes | 2 | 2010 | 1006 | 0.020 |
Why?
|
| Fluorouracil | 1 | 2017 | 1630 | 0.020 |
Why?
|
| Gene Knockout Techniques | 1 | 2015 | 803 | 0.020 |
Why?
|
| Cell Growth Processes | 1 | 2012 | 384 | 0.020 |
Why?
|
| Lactation | 2 | 2008 | 395 | 0.020 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 1 | 2014 | 900 | 0.020 |
Why?
|
| RNA Interference | 2 | 2010 | 2846 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2015 | 747 | 0.020 |
Why?
|
| Organophosphorus Compounds | 1 | 2013 | 202 | 0.020 |
Why?
|
| Cricetinae | 2 | 2005 | 2427 | 0.020 |
Why?
|
| Glomus Tumor | 1 | 2012 | 62 | 0.020 |
Why?
|
| Cyclin E | 1 | 2012 | 157 | 0.020 |
Why?
|
| Coculture Techniques | 1 | 2015 | 1340 | 0.020 |
Why?
|
| Software | 1 | 2005 | 4420 | 0.020 |
Why?
|
| Neuroglia | 1 | 2017 | 944 | 0.020 |
Why?
|
| Protein Kinases | 1 | 1998 | 1612 | 0.020 |
Why?
|
| Epigenesis, Genetic | 2 | 2017 | 3758 | 0.020 |
Why?
|
| Lectins, C-Type | 1 | 2014 | 591 | 0.020 |
Why?
|
| Lysophospholipase | 1 | 2010 | 65 | 0.020 |
Why?
|
| Receptors, Antigen, T-Cell | 2 | 2015 | 2536 | 0.020 |
Why?
|
| Lymph Nodes | 2 | 2018 | 3491 | 0.020 |
Why?
|
| Nuclear Receptor Co-Repressor 2 | 1 | 2010 | 33 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 2 | 1997 | 6067 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2013 | 698 | 0.020 |
Why?
|
| Endothelium | 2 | 2003 | 764 | 0.020 |
Why?
|
| DNA Methylation | 2 | 2017 | 4374 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2013 | 616 | 0.020 |
Why?
|
| Developmental Biology | 1 | 2010 | 79 | 0.020 |
Why?
|
| Prostatic Neoplasms | 1 | 2013 | 11341 | 0.020 |
Why?
|
| Pulmonary Alveoli | 1 | 2012 | 653 | 0.020 |
Why?
|
| Cell Cycle | 3 | 2004 | 2937 | 0.020 |
Why?
|
| Chromosome Mapping | 2 | 2013 | 4625 | 0.020 |
Why?
|
| Caspases | 1 | 2013 | 878 | 0.020 |
Why?
|
| Reticulocytes | 2 | 2001 | 288 | 0.020 |
Why?
|
| Helix-Loop-Helix Motifs | 2 | 1999 | 96 | 0.020 |
Why?
|
| Drosophila Proteins | 1 | 1999 | 1699 | 0.020 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2010 | 293 | 0.020 |
Why?
|
| Autoimmune Diseases | 1 | 2001 | 2250 | 0.020 |
Why?
|
| Heterozygote | 2 | 2007 | 2797 | 0.020 |
Why?
|
| Respiratory Mucosa | 1 | 2012 | 441 | 0.020 |
Why?
|
| Aged | 2 | 2020 | 168995 | 0.020 |
Why?
|
| Survival Rate | 2 | 2015 | 12806 | 0.020 |
Why?
|
| Retroviridae | 2 | 2005 | 850 | 0.020 |
Why?
|
| Intestine, Large | 1 | 2008 | 68 | 0.020 |
Why?
|
| beta-Globins | 1 | 2009 | 108 | 0.020 |
Why?
|
| Dexamethasone | 1 | 2016 | 1928 | 0.020 |
Why?
|
| Dermatitis, Allergic Contact | 1 | 2010 | 111 | 0.020 |
Why?
|
| Organic Anion Transporters, Sodium-Dependent | 1 | 2008 | 26 | 0.020 |
Why?
|
| Coronary Vessels | 1 | 2000 | 3112 | 0.020 |
Why?
|
| Repetitive Sequences, Amino Acid | 1 | 2008 | 93 | 0.020 |
Why?
|
| Cell Separation | 2 | 2006 | 1720 | 0.020 |
Why?
|
| Histone Acetyltransferases | 1 | 2010 | 337 | 0.020 |
Why?
|
| Neomycin | 2 | 1999 | 93 | 0.020 |
Why?
|
| Growth Hormone | 1 | 2010 | 568 | 0.020 |
Why?
|
| Exons | 2 | 2008 | 2391 | 0.020 |
Why?
|
| Phosphoproteins | 2 | 2009 | 2441 | 0.020 |
Why?
|
| Lipoylation | 1 | 2009 | 88 | 0.020 |
Why?
|
| Morphogenesis | 2 | 2004 | 740 | 0.020 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2012 | 1446 | 0.020 |
Why?
|
| Interneurons | 2 | 2005 | 591 | 0.020 |
Why?
|
| Cell Membrane Structures | 1 | 2007 | 24 | 0.020 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2010 | 694 | 0.020 |
Why?
|
| Lentivirus | 1 | 2010 | 505 | 0.020 |
Why?
|
| Serine Endopeptidases | 1 | 2013 | 1021 | 0.020 |
Why?
|
| Acetylation | 1 | 2010 | 1062 | 0.020 |
Why?
|
| Leukemia, T-Cell | 2 | 1999 | 101 | 0.020 |
Why?
|
| Epidermal Growth Factor | 1 | 2010 | 695 | 0.020 |
Why?
|
| Ploidies | 1 | 2008 | 275 | 0.020 |
Why?
|
| Myosin Light Chains | 1 | 2007 | 121 | 0.020 |
Why?
|
| Genome | 1 | 2015 | 1739 | 0.020 |
Why?
|
| Melanoma, Experimental | 1 | 2010 | 562 | 0.020 |
Why?
|
| Spleen | 2 | 2005 | 2298 | 0.020 |
Why?
|
| Sex Differentiation | 1 | 2007 | 73 | 0.020 |
Why?
|
| Cell Polarity | 1 | 2010 | 638 | 0.020 |
Why?
|
| Mammary Glands, Animal | 1 | 2008 | 265 | 0.020 |
Why?
|
| Enterocytes | 1 | 2008 | 220 | 0.020 |
Why?
|
| DNA Transposable Elements | 1 | 2010 | 752 | 0.020 |
Why?
|
| Sequence Analysis, RNA | 1 | 2015 | 2003 | 0.020 |
Why?
|
| GATA6 Transcription Factor | 1 | 2006 | 49 | 0.020 |
Why?
|
| Multiprotein Complexes | 2 | 2007 | 1120 | 0.020 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2010 | 1128 | 0.020 |
Why?
|
| Mice, Inbred CBA | 1 | 2007 | 436 | 0.020 |
Why?
|
| Disease Progression | 1 | 2023 | 13505 | 0.020 |
Why?
|
| Lymphocyte Count | 1 | 2008 | 780 | 0.020 |
Why?
|
| Blood Platelets | 1 | 1997 | 2522 | 0.020 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2007 | 225 | 0.020 |
Why?
|
| Thymus Gland | 2 | 2001 | 1246 | 0.020 |
Why?
|
| Anaphylatoxins | 1 | 2005 | 21 | 0.020 |
Why?
|
| Tyrphostins | 1 | 2005 | 63 | 0.020 |
Why?
|
| Mutant Proteins | 1 | 2008 | 492 | 0.020 |
Why?
|
| Survival Analysis | 2 | 2013 | 10185 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 2007 | 871 | 0.020 |
Why?
|
| RNA, Untranslated | 2 | 2001 | 459 | 0.020 |
Why?
|
| Anemia, Hypochromic | 1 | 2005 | 63 | 0.020 |
Why?
|
| 3T3 Cells | 2 | 1997 | 1085 | 0.020 |
Why?
|
| Endothelium, Vascular | 1 | 1998 | 4437 | 0.020 |
Why?
|
| Proto-Oncogene Protein c-fli-1 | 1 | 2006 | 104 | 0.020 |
Why?
|
| Genetic Loci | 1 | 2015 | 2618 | 0.020 |
Why?
|
| Tissue Culture Techniques | 1 | 2006 | 290 | 0.020 |
Why?
|
| PC12 Cells | 1 | 2005 | 317 | 0.020 |
Why?
|
| Epigenomics | 1 | 2011 | 936 | 0.020 |
Why?
|
| Symporters | 1 | 2008 | 361 | 0.020 |
Why?
|
| Immunohistochemistry | 2 | 2015 | 11064 | 0.020 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2009 | 633 | 0.020 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2007 | 459 | 0.020 |
Why?
|
| Breast Neoplasms | 2 | 2010 | 21065 | 0.020 |
Why?
|
| Sequence Alignment | 2 | 2000 | 2178 | 0.020 |
Why?
|
| Killer Cells, Natural | 2 | 2005 | 2204 | 0.020 |
Why?
|
| Subcellular Fractions | 1 | 2005 | 532 | 0.020 |
Why?
|
| Prostate | 1 | 2013 | 1793 | 0.010 |
Why?
|
| Genes, Dominant | 1 | 2007 | 863 | 0.010 |
Why?
|
| Genome-Wide Association Study | 2 | 2013 | 12602 | 0.010 |
Why?
|
| Myocardium | 2 | 2007 | 4688 | 0.010 |
Why?
|
| Guinea Pigs | 1 | 2005 | 1314 | 0.010 |
Why?
|
| Wound Healing | 1 | 2015 | 2786 | 0.010 |
Why?
|
| Middle Aged | 1 | 2018 | 220175 | 0.010 |
Why?
|
| Receptors, CXCR3 | 1 | 2005 | 238 | 0.010 |
Why?
|
| Wiskott-Aldrich Syndrome Protein Family | 1 | 2003 | 35 | 0.010 |
Why?
|
| Adult | 1 | 2018 | 219847 | 0.010 |
Why?
|
| Regeneration | 1 | 2012 | 1506 | 0.010 |
Why?
|
| Chick Embryo | 1 | 2005 | 981 | 0.010 |
Why?
|
| Proteomics | 1 | 2017 | 3810 | 0.010 |
Why?
|
| Cranial Nerves | 1 | 2004 | 98 | 0.010 |
Why?
|
| Genes, Lethal | 1 | 2004 | 225 | 0.010 |
Why?
|
| Peroxiredoxins | 1 | 2003 | 51 | 0.010 |
Why?
|
| Gene Rearrangement | 2 | 1998 | 1122 | 0.010 |
Why?
|
| Iron Overload | 1 | 2005 | 240 | 0.010 |
Why?
|
| Oxidoreductases | 1 | 2005 | 412 | 0.010 |
Why?
|
| Introns | 1 | 2006 | 978 | 0.010 |
Why?
|
| Sex-Determining Region Y Protein | 1 | 2002 | 15 | 0.010 |
Why?
|
| Progesterone Reductase | 1 | 2002 | 14 | 0.010 |
Why?
|
| Fushi Tarazu Transcription Factors | 1 | 2002 | 24 | 0.010 |
Why?
|
| Immunoprecipitation | 1 | 2005 | 877 | 0.010 |
Why?
|
| Steroid Isomerases | 1 | 2002 | 19 | 0.010 |
Why?
|
| Cholesterol Side-Chain Cleavage Enzyme | 1 | 2002 | 27 | 0.010 |
Why?
|
| Base Composition | 1 | 2003 | 290 | 0.010 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2004 | 458 | 0.010 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2013 | 2823 | 0.010 |
Why?
|
| Sphenoid Bone | 1 | 2004 | 177 | 0.010 |
Why?
|
| Wiskott-Aldrich Syndrome | 1 | 2003 | 130 | 0.010 |
Why?
|
| Animals, Genetically Modified | 1 | 2008 | 1553 | 0.010 |
Why?
|
| Pseudopodia | 1 | 2003 | 168 | 0.010 |
Why?
|
| Sertoli Cells | 1 | 2002 | 50 | 0.010 |
Why?
|
| Steroidogenic Factor 1 | 1 | 2002 | 45 | 0.010 |
Why?
|
| Endosomes | 1 | 2005 | 519 | 0.010 |
Why?
|
| Sulfobromophthalein | 1 | 2002 | 9 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2006 | 729 | 0.010 |
Why?
|
| p-Aminohippuric Acid | 1 | 2002 | 36 | 0.010 |
Why?
|
| Taurocholic Acid | 1 | 2002 | 43 | 0.010 |
Why?
|
| Point Mutation | 1 | 2008 | 1594 | 0.010 |
Why?
|
| Biopolymers | 1 | 2003 | 185 | 0.010 |
Why?
|
| Steroid 17-alpha-Hydroxylase | 1 | 2002 | 99 | 0.010 |
Why?
|
| Leukopoiesis | 1 | 2002 | 55 | 0.010 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2009 | 1314 | 0.010 |
Why?
|
| Flavonoids | 1 | 2005 | 444 | 0.010 |
Why?
|
| Chemotaxis | 1 | 2005 | 598 | 0.010 |
Why?
|
| Probenecid | 1 | 2002 | 75 | 0.010 |
Why?
|
| Thiamine | 1 | 2003 | 160 | 0.010 |
Why?
|
| Doxorubicin | 1 | 2009 | 2207 | 0.010 |
Why?
|
| Immunoblotting | 1 | 2005 | 1649 | 0.010 |
Why?
|
| H-Y Antigen | 1 | 2001 | 42 | 0.010 |
Why?
|
| Lymphopoiesis | 1 | 2003 | 133 | 0.010 |
Why?
|
| Glomerulonephritis, Membranoproliferative | 1 | 2001 | 40 | 0.010 |
Why?
|
| Pregnancy | 3 | 2015 | 29725 | 0.010 |
Why?
|
| Clonal Deletion | 1 | 2001 | 74 | 0.010 |
Why?
|
| Polyribosomes | 1 | 2001 | 109 | 0.010 |
Why?
|
| Heart Valves | 1 | 2003 | 285 | 0.010 |
Why?
|
| WT1 Proteins | 1 | 2002 | 184 | 0.010 |
Why?
|
| E2F4 Transcription Factor | 1 | 2001 | 32 | 0.010 |
Why?
|
| E2F3 Transcription Factor | 1 | 2001 | 36 | 0.010 |
Why?
|
| Oligodendroglia | 1 | 2005 | 535 | 0.010 |
Why?
|
| RNA | 2 | 2003 | 2721 | 0.010 |
Why?
|
| Interleukin-5 | 1 | 2002 | 270 | 0.010 |
Why?
|
| Asthma | 1 | 2000 | 6167 | 0.010 |
Why?
|
| Cyclic AMP | 1 | 2005 | 1455 | 0.010 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2016 | 5230 | 0.010 |
Why?
|
| Protoporphyrins | 1 | 2001 | 165 | 0.010 |
Why?
|
| Neural Crest | 1 | 2003 | 279 | 0.010 |
Why?
|
| DNA, Single-Stranded | 1 | 2003 | 360 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 2005 | 1792 | 0.010 |
Why?
|
| Splenomegaly | 1 | 2001 | 189 | 0.010 |
Why?
|
| Ribonucleases | 1 | 2001 | 277 | 0.010 |
Why?
|
| Hemoglobinuria, Paroxysmal | 1 | 2001 | 95 | 0.010 |
Why?
|
| Foot | 1 | 2005 | 573 | 0.010 |
Why?
|
| Evolution, Molecular | 1 | 2009 | 1884 | 0.010 |
Why?
|
| Eukaryotic Initiation Factor-2 | 1 | 2001 | 180 | 0.010 |
Why?
|
| Models, Immunological | 1 | 2003 | 513 | 0.010 |
Why?
|
| Complement C3a | 1 | 2000 | 66 | 0.010 |
Why?
|
| Mass Spectrometry | 1 | 2007 | 2192 | 0.010 |
Why?
|
| Muridae | 1 | 2000 | 56 | 0.010 |
Why?
|
| Plethysmography | 1 | 2000 | 174 | 0.010 |
Why?
|
| Methacholine Chloride | 1 | 2000 | 222 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2015 | 11141 | 0.010 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2006 | 1484 | 0.010 |
Why?
|
| Jurkat Cells | 1 | 2001 | 736 | 0.010 |
Why?
|
| Xenopus | 1 | 2002 | 717 | 0.010 |
Why?
|
| Lipids | 1 | 2011 | 3336 | 0.010 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2016 | 5640 | 0.010 |
Why?
|
| Pyrazoles | 1 | 2010 | 1992 | 0.010 |
Why?
|
| Indicators and Reagents | 1 | 2001 | 461 | 0.010 |
Why?
|
| Molecular Targeted Therapy | 1 | 2011 | 2805 | 0.010 |
Why?
|
| Transcription Factor 7-Like 1 Protein | 1 | 1999 | 23 | 0.010 |
Why?
|
| Heme | 1 | 2001 | 313 | 0.010 |
Why?
|
| Artificial Gene Fusion | 1 | 1999 | 56 | 0.010 |
Why?
|
| Choroid Plexus | 1 | 2002 | 237 | 0.010 |
Why?
|
| Deafness | 1 | 2003 | 456 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2001 | 1746 | 0.010 |
Why?
|
| Cerebrospinal Fluid | 1 | 2002 | 544 | 0.010 |
Why?
|
| TCF Transcription Factors | 1 | 1999 | 138 | 0.010 |
Why?
|
| DNA Ligases | 1 | 1998 | 82 | 0.010 |
Why?
|
| Blood Cells | 1 | 2001 | 305 | 0.010 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2011 | 2297 | 0.010 |
Why?
|
| GATA3 Transcription Factor | 1 | 1999 | 152 | 0.010 |
Why?
|
| MAP Kinase Signaling System | 1 | 2005 | 1483 | 0.010 |
Why?
|
| Vitelline Membrane | 1 | 1998 | 3 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2003 | 1697 | 0.010 |
Why?
|
| Pyridines | 1 | 2010 | 2877 | 0.010 |
Why?
|
| Blood Group Antigens | 1 | 2000 | 187 | 0.010 |
Why?
|
| Immunosuppressive Agents | 1 | 2011 | 4168 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 2001 | 2558 | 0.010 |
Why?
|
| Genetic Variation | 1 | 2013 | 6540 | 0.010 |
Why?
|
| Caseins | 1 | 1998 | 103 | 0.010 |
Why?
|
| K562 Cells | 1 | 2000 | 640 | 0.010 |
Why?
|
| beta-Galactosidase | 1 | 1999 | 575 | 0.010 |
Why?
|
| Radiation, Ionizing | 1 | 1998 | 251 | 0.010 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2002 | 854 | 0.010 |
Why?
|
| Protein Transport | 1 | 2003 | 1966 | 0.010 |
Why?
|
| Vertebrates | 1 | 1999 | 228 | 0.010 |
Why?
|
| Biological Transport | 1 | 2002 | 2087 | 0.010 |
Why?
|
| Hypersensitivity, Immediate | 1 | 2000 | 345 | 0.010 |
Why?
|
| Receptor, TIE-2 | 1 | 1998 | 177 | 0.010 |
Why?
|
| Genes, Essential | 1 | 1998 | 184 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2007 | 3764 | 0.010 |
Why?
|
| Lac Operon | 1 | 1997 | 237 | 0.010 |
Why?
|
| Hemoglobins | 1 | 2003 | 1521 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2015 | 20048 | 0.010 |
Why?
|
| Intestinal Mucosa | 1 | 2008 | 3023 | 0.010 |
Why?
|
| Adenoviridae | 1 | 2001 | 1084 | 0.010 |
Why?
|
| Saccharomyces cerevisiae | 2 | 1999 | 2702 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2005 | 6242 | 0.010 |
Why?
|
| Lymphoid Tissue | 1 | 1998 | 446 | 0.010 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2005 | 1811 | 0.010 |
Why?
|
| Bone Marrow Transplantation | 1 | 2004 | 2696 | 0.010 |
Why?
|
| Peptides | 1 | 2008 | 4358 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2005 | 4127 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 1999 | 1765 | 0.010 |
Why?
|
| Diabetes Complications | 1 | 2003 | 1342 | 0.010 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1998 | 783 | 0.010 |
Why?
|
| Brain | 2 | 2002 | 26912 | 0.010 |
Why?
|
| Adipose Tissue | 1 | 2008 | 3293 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2000 | 2262 | 0.010 |
Why?
|
| Longevity | 1 | 2003 | 1050 | 0.010 |
Why?
|
| Pericardium | 1 | 2000 | 675 | 0.010 |
Why?
|
| Cell Membrane | 1 | 2005 | 3683 | 0.010 |
Why?
|
| Mutagenesis, Insertional | 1 | 1998 | 652 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 2005 | 3207 | 0.010 |
Why?
|
| Milk | 1 | 1998 | 443 | 0.010 |
Why?
|
| Reactive Oxygen Species | 1 | 2003 | 2138 | 0.010 |
Why?
|
| DNA | 2 | 1999 | 7236 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 1997 | 1433 | 0.010 |
Why?
|
| Cytoplasm | 1 | 2000 | 1518 | 0.010 |
Why?
|
| Cell Culture Techniques | 1 | 2002 | 1663 | 0.010 |
Why?
|
| Immunologic Memory | 1 | 2001 | 1354 | 0.010 |
Why?
|
| Time Factors | 3 | 2001 | 40133 | 0.010 |
Why?
|
| Stress, Physiological | 1 | 2001 | 1395 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2005 | 4357 | 0.010 |
Why?
|
| Lymphoma | 1 | 2003 | 1899 | 0.010 |
Why?
|
| Inflammation | 2 | 2005 | 10757 | 0.010 |
Why?
|
| Lymphocytes | 1 | 2001 | 2612 | 0.010 |
Why?
|
| DNA Damage | 1 | 2003 | 2442 | 0.010 |
Why?
|
| Mammals | 1 | 1999 | 1129 | 0.010 |
Why?
|
| Bone and Bones | 1 | 2004 | 2560 | 0.010 |
Why?
|
| Neutrophils | 1 | 2005 | 3770 | 0.010 |
Why?
|
| Models, Cardiovascular | 1 | 1998 | 974 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 2003 | 3107 | 0.010 |
Why?
|
| Sarcoma | 1 | 2003 | 1786 | 0.010 |
Why?
|
| Ovarian Neoplasms | 1 | 2009 | 4875 | 0.010 |
Why?
|
| Phylogeny | 1 | 1999 | 2775 | 0.010 |
Why?
|
| Drosophila | 1 | 1999 | 1492 | 0.010 |
Why?
|
| Axons | 1 | 1999 | 1672 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2000 | 2909 | 0.010 |
Why?
|
| Gestational Age | 1 | 1999 | 3564 | 0.010 |
Why?
|
| Anemia | 1 | 1999 | 1511 | 0.010 |
Why?
|
| DNA Repair | 1 | 1998 | 2039 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2000 | 4717 | 0.000 |
Why?
|
| Neovascularization, Pathologic | 1 | 1999 | 2641 | 0.000 |
Why?
|
| Homeostasis | 1 | 1999 | 3305 | 0.000 |
Why?
|
| Mortality | 1 | 1998 | 2916 | 0.000 |
Why?
|
| Heart Defects, Congenital | 1 | 2003 | 4668 | 0.000 |
Why?
|
| Neoplasm Proteins | 1 | 1999 | 3613 | 0.000 |
Why?
|
| Diabetes Mellitus | 1 | 2003 | 5884 | 0.000 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2003 | 17766 | 0.000 |
Why?
|